ISRCTN75232398已完成不适用
A double-blind, placebo-controlled trial of ciprofloxacin prophylaxis in patients with acute necrotising pancreatitis
Hospital Universitari De Bellvitge (Spain)0 个研究点目标入组 80 人开始时间: 2008年4月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •All adult patients of either sex:
- •1. Without previous antibiotic treatment
- •2. With detectable pancreatic necrosis in a contrast-enhanced computed tomography (CT) scan 25 performed within 48 - 72 hours of admission
排除标准
- •1. Antibiotic allergy
- •2. Clinical evidence of sepsis on admission
研究者
相似试验
进行中（未招募）
不适用
A randomised, ciprofloxacin-controlled study of two prulifloxacin regimens in antibiotic prophylaxis for transrectal prostatic biopsy TPB .EUCTR2005-002888-88-ITANGELINI135
尚未招募
2 期
Treatment Evaluation of Alcohol and MoodAlcoholismDepressionACTRN12606000413527Professor Doug Sellman220
进行中（未招募）
不适用
Safety and Efficacy of Cariprazine as an Adjunctive to AntidepressantTherapy in Major Depressive DisorderMajor Depressive DisorderEUCTR2011-005179-18-SKForest Research Institute, Inc810
进行中（未招募）
1 期
.MedDRA version: 16.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873MedDRA version: 16.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873Major Depressive DisorderEUCTR2011-005179-18-SEForest Research Institute, Inc819
进行中（未招募）
不适用
Safety and Efficacy of Cariprazine as an Adjunctive to AntidepressantTherapy in Major Depressive DisorderMajor Depressive DisorderEUCTR2011-005179-18-EEForest Research Institute, Inc810